Barry P. Flannelly
CIK: 0001615842
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Jun 15, 2026TARA
Protara Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
31K shares- - Jul 16, 2025INCY
INCYTE CORP
Sale(S)Direct1.3K shares at avg. $68.36$92K - Jul 15, 2025INCY
INCYTE CORP
Sale(S)Direct1.2K shares at avg. $69.86$83K - Jul 15, 2025INCY
INCYTE CORP
Tax Payment(F)Direct1.1K shares at avg. $68.25$78K - Jul 14, 2025INCY
INCYTE CORP
Tax Payment(F)Direct922 shares at avg. $69.98$65K - Jul 3, 2025INCY
INCYTE CORP
Sale(S)Direct10.9K shares at avg. $68.15$743K - Jul 2, 2025INCY
INCYTE CORP
Tax Payment(F)Direct9.1K shares at avg. $68.17$617K - Jun 12, 2025TARA
Protara Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
24K shares- - Apr 1, 2025INCY
INCYTE CORP
Award(A)Direct11.2K shares- - Apr 1, 2025INCY
INCYTE CORP
Award(A)Direct15K shares- - Mar 14, 2025INCY
INCYTE CORP
Sale(S)Direct461 shares at avg. $67.85$31K - Mar 14, 2025INCY
INCYTE CORP
Sale(S)Direct199 shares at avg. $67.88$14K - Mar 14, 2025INCY
INCYTE CORP
Sale(S)Direct19.1K shares at avg. $67.68$1.3M - Jan 17, 2025INCY
INCYTE CORP
Award(A)DirectEmployee Stock Option (right to buy)
20.1K shares- - Jan 15, 2025INCY
INCYTE CORP
Tax Payment(F)Direct3.2K shares at avg. $72.46$229K - Dec 9, 2024INCY
INCYTE CORP
Tax Payment(F)Direct1.5K shares at avg. $72.11$109K - Nov 6, 2024INCY
INCYTE CORP
Sale(S)Direct2.3K shares at avg. $78.21$176K - Nov 6, 2024INCY
INCYTE CORP
Sale(S)Direct1.4K shares at avg. $82.00$117K - Nov 6, 2024INCY
INCYTE CORP
Exercise(M)Direct2.3K shares at avg. $68.62$155K - Nov 6, 2024INCY
INCYTE CORP
Exercise(M)Direct1.4K shares at avg. $72.27$103K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  TARA Protara Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 31,000 | - | - | Direct |
| Jul 16, 2025 |  INCY INCYTE CORP | Sale(S) | 1,340 | $68.36 | $91,602 | Direct |
| Jul 15, 2025 | INCY INCYTE CORP | Sale(S) | 1,192 | $69.86 | $83,273 | Direct |
| Jul 15, 2025 | INCY INCYTE CORP | Tax Payment(F) | 1,141 | $68.25 | $77,873 | Direct |
| Jul 14, 2025 | INCY INCYTE CORP | Tax Payment(F) | 922 | $69.98 | $64,522 | Direct |
| Jul 3, 2025 | INCY INCYTE CORP | Sale(S) | 10,903 | $68.15 | $743,039 | Direct |
| Jul 2, 2025 | INCY INCYTE CORP | Tax Payment(F) | 9,055 | $68.17 | $617,279 | Direct |
| Jun 12, 2025 | TARA Protara Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 24,000 | - | - | Direct |
| Apr 1, 2025 | INCY INCYTE CORP | Award(A) | 11,159 | - | - | Direct |
| Apr 1, 2025 | INCY INCYTE CORP | Award(A) | 14,976 | - | - | Direct |
| Mar 14, 2025 | INCY INCYTE CORP | Sale(S) | 461 | $67.85 | $31,279 | Direct |
| Mar 14, 2025 | INCY INCYTE CORP | Sale(S) | 199 | $67.88 | $13,508 | Direct |
| Mar 14, 2025 | INCY INCYTE CORP | Sale(S) | 19,147 | $67.68 | $1,295,869 | Direct |
| Jan 17, 2025 | INCY INCYTE CORP | Award(A) Employee Stock Option (right to buy) | 20,144 | - | - | Direct |
| Jan 15, 2025 | INCY INCYTE CORP | Tax Payment(F) | 3,158 | $72.46 | $228,829 | Direct |
| Dec 9, 2024 | INCY INCYTE CORP | Tax Payment(F) | 1,510 | $72.11 | $108,886 | Direct |
| Nov 6, 2024 | INCY INCYTE CORP | Sale(S) | 2,256 | $78.21 | $176,442 | Direct |
| Nov 6, 2024 | INCY INCYTE CORP | Sale(S) | 1,424 | $82.00 | $116,768 | Direct |
| Nov 6, 2024 | INCY INCYTE CORP | Exercise(M) | 2,256 | $68.62 | $154,807 | Direct |
| Nov 6, 2024 | INCY INCYTE CORP | Exercise(M) | 1,424 | $72.27 | $102,912 | Direct |
1-20 of 20 transactions
About Flannelly Barry P
Flannelly Barry P (SEC CIK 0001615842) files insider reports with the SEC as Director of Protara Therapeutics, Inc. (TARA) and EVP & General Manager US of INCYTE CORP (INCY).
Signal8 holds 11 ownership filings by Flannelly Barry P, all Form 4s, filed between Nov 8, 2024 and Jun 16, 2026. Those filings report 20 transactions, from Nov 6, 2024 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Flannelly Barry P's filings is in NEW YORK, NY.
Recent filings by Flannelly Barry P
- Jun 15, 2026: Grant or award of TARA derivative securities (Form 4, code A).
- Jul 16, 2025: Open-market sale of INCY shares (Form 4, code S).
- Jul 15, 2025: Open-market sale of INCY shares (Form 4, code S).
- Jul 15, 2025: Tax withholding of INCY shares (Form 4, code F).
- Jul 14, 2025: Tax withholding of INCY shares (Form 4, code F).
Other insiders filing for Protara Therapeutics, Inc. (TARA)
- Shefferman Jesse, CEO and President
- Levy Richard S, Director
- Solomon Michael Edward, Director
- Smith Cynthia, Director
- SARGEN GREGORY, Director
- Huang Jane, Director